Novozymes A/S (ETR:NZM2)

Market Cap	24.99B
Revenue (ttm)	4.14B +19.3%
Net Income	547.00M +74.4%
EPS	1.91 +151.6%
Shares Out	n/a
PE Ratio	45.69
Forward PE	25.90
Dividend	0.86 (1.60%)
Ex-Dividend Date	Aug 25, 2025

Volume	n/a
Average Volume	224
Open	59.12
Previous Close	59.12
Day's Range	59.12 - 59.12
52-Week Range	50.34 - 59.12
Beta	n/a
RSI	44.40
Earnings Date	Feb 25, 2026

About Novozymes

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional lau...

• Industry: Miscellaneous Chemical Products
• Founded: 1925
• Employees: 10,582
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: NZM2

Financial Performance

In 2024, Novozymes's revenue was 3.83 billion, an increase of 59.58% compared to the previous year's 2.40 billion. Earnings were 305.80 million, a decrease of -24.66%.